Randomized trial evaluates autoantibody presence affecting progression from ocular to generalized myasthenia gravis, suggesting increased risk.
To determine the proportion of ocular myasthenia gravis (OMG) patients with multiple autoantibody positivity and evaluate whether the presence of multiple autoantibodies is associated with an increased risk of progression from OMG to generalized myasthenia gravis (GMG).
No takes yet. Share an insight, caveat, or question.
Kwak et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: